A Phase I , Study to Investigate Pharmacokinetics and Pharmacodynamics of Single and Multiple Dose of CJ-12420 50mg, 100mg in Helicobacter Pylori ?
Latest Information Update: 16 Jul 2020
At a glance
- Drugs Tegoprazan (Primary)
- Indications Helicobacter pylori infections
- Focus Pharmacokinetics
- Sponsors CJ HealthCare; HK inno.N
- 07 Jan 2017 New trial record